SCHEMBL31236136

SCHEMBL31236136

Cc1cc2[nH]c(=O)c(=O)[nH]c2cc1S(N)(=O)=O

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PKM P14618 5/20 0.59
▸ GRIN2D O15399 2/20 0.59
▸ GRIN3B O60391 2/20 0.59
▸ GRIN1 Q05586 2/20 0.59
▸ GRIN2A Q12879 2/20 0.59
▸ GRIN2B Q13224 2/20 0.59
▸ GRIN2C Q14957 2/20 0.59
▸ GRIN3A Q8TCU5 2/20 0.59
▸ LMNA P02545 4/20 0.52
▸ MEN1 O00255 1/20 0.52
▸ KMT2A Q03164 1/20 0.52
▸ GAA P10253 1/20 0.51
▸ THRB P10828 2/20 0.48
▸ POLB P06746 2/20 0.48
▸ MAPT P10636 1/20 0.48
▸ GRIA1 P42261 1/20 0.47
▸ GRIA2 P42262 1/20 0.47
▸ GRIA3 P42263 1/20 0.47
▸ GRIA4 P48058 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24876001 0.84 GRIN2D (0.64) PKMGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL24875976 0.81 GRIN2D (0.59) PKMGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL30210932 0.81 GRIN2D (0.59) PKMGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL121942 0.76 GRIN2D (1.00) PKMGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL24876742 0.74 PKM (0.76) PKMLMNAMEN1KMT2AGAA
SCHEMBL11511279 0.74 KDM4E (0.52) PKMLMNA
SCHEMBL24876095 0.73 LMNA (0.69) PKMLMNAMEN1KMT2AGAA
SCHEMBL24876241 0.73 LMNA (0.78) PKMLMNAMEN1KMT2AGAA
SCHEMBL28827972 0.72 ALDH1A1 (0.50) LMNAGAAPOLB
SCHEMBL24876741 0.72 LMNA (0.76) PKMLMNAMEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240376084-A1 INHIBITORS OF ALPHA-HEMOLYSIN OF STAPHYLOCOCCUS AUREUS HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH (DE) 2024-11-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240376084-A1 INHIBITORS OF ALPHA-HEMOLYSIN OF STAPHYLOCOCCUS AUREUS SERPINB1, LTA, SERPINC1 PKM 4749/4885GRIN2D 4864/4885GRIN3B 4680/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback